Custom Content Manager
Latest Content From Tiffany Quinn
On this episode, the team will discuss how the SARS-CoV-2 virus affects our brain. This podcast will untangle the disparate effects involved, covering everything from a subdued sense of smell to serious brain inflammation and damage.VIEW
In this episode we speak with Pieter Peeters, Leader of High Dimensional Biology and Discovery Data Sciences Group at Janssen Research & Development, who tells us more about the evolution of artificial intelligence, and how it can be used to discover and develop new drugs.VIEW
In this episode, the Technology Networks team discuss drug treatments to combat SARS-CoV-2. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic?
In this episode we speak with Dr Stephen Wright, Consultant in Medicines Development from Limber Strategic, who talks to us about the clinical development of a drug, including how clinical trials are designed and the role of regulatory authorities in the process.VIEW
In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.VIEW
In this episode, we speak with Tomasz Kostrzewski, Director of Biology at CN Bio about how drugs are developed, including the challenges faced when designing and developing a drug, how drug discovery has evolved, and what trends we can expect to see in the future.VIEW